Literature DB >> 28714978

α-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming.

Pu-Ste Liu1,2, Haiping Wang1,2, Xiaoyun Li1,2, Tung Chao1,2, Tony Teav3, Stefan Christen4,5, Giusy Di Conza1,2, Wan-Chen Cheng1,2, Chih-Hung Chou6,7, Magdalena Vavakova1,2, Charlotte Muret1,2, Koen Debackere8,9, Massimiliano Mazzone8,9, Hsien-Da Huang6,7, Sarah-Maria Fendt4,5, Julijana Ivanisevic3, Ping-Chih Ho1,2.   

Abstract

Glutamine metabolism provides synergistic support for macrophage activation and elicitation of desirable immune responses; however, the underlying mechanisms regulated by glutamine metabolism to orchestrate macrophage activation remain unclear. Here we show that the production of α-ketoglutarate (αKG) via glutaminolysis is important for alternative (M2) activation of macrophages, including engagement of fatty acid oxidation (FAO) and Jmjd3-dependent epigenetic reprogramming of M2 genes. This M2-promoting mechanism is further modulated by a high αKG/succinate ratio, whereas a low ratio strengthens the proinflammatory phenotype in classically activated (M1) macrophages. As such, αKG contributes to endotoxin tolerance after M1 activation. This study reveals new mechanistic regulations by which glutamine metabolism tailors the immune responses of macrophages through metabolic and epigenetic reprogramming.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28714978     DOI: 10.1038/ni.3796

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  45 in total

1.  Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity.

Authors:  Eoin P Cummins; Edurne Berra; Katrina M Comerford; Amandine Ginouves; Kathleen T Fitzgerald; Fergal Seeballuck; Catherine Godson; Jens E Nielsen; Paul Moynagh; Jacques Pouyssegur; Cormac T Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-17       Impact factor: 11.205

2.  Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders.

Authors:  S Sawhney; P Woo; K J Murray
Journal:  Arch Dis Child       Date:  2001-11       Impact factor: 3.791

3.  Epigenetic regulation of the alternatively activated macrophage phenotype.

Authors:  Makoto Ishii; Haitao Wen; Callie A S Corsa; Tianju Liu; Ana L Coelho; Ronald M Allen; William F Carson; Karen A Cavassani; Xiangzhi Li; Nicholas W Lukacs; Cory M Hogaboam; Yali Dou; Steven L Kunkel
Journal:  Blood       Date:  2009-06-30       Impact factor: 22.113

4.  Metabolic Reprogramming Mediated by the mTORC2-IRF4 Signaling Axis Is Essential for Macrophage Alternative Activation.

Authors:  Stanley Ching-Cheng Huang; Amber M Smith; Bart Everts; Marco Colonna; Erika L Pearce; Joel D Schilling; Edward J Pearce
Journal:  Immunity       Date:  2016-10-18       Impact factor: 31.745

5.  Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation.

Authors:  Juan-Carlos Rodríguez-Prados; Paqui G Través; Jimena Cuenca; Daniel Rico; Julián Aragonés; Paloma Martín-Sanz; Marta Cascante; Lisardo Boscá
Journal:  J Immunol       Date:  2010-05-24       Impact factor: 5.422

6.  Succinate Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory Macrophages.

Authors:  Evanna L Mills; Beth Kelly; Angela Logan; Ana S H Costa; Mukund Varma; Clare E Bryant; Panagiotis Tourlomousis; J Henry M Däbritz; Eyal Gottlieb; Isabel Latorre; Sinéad C Corr; Gavin McManus; Dylan Ryan; Howard T Jacobs; Marten Szibor; Ramnik J Xavier; Thomas Braun; Christian Frezza; Michael P Murphy; Luke A O'Neill
Journal:  Cell       Date:  2016-09-22       Impact factor: 41.582

7.  Interferon-γ regulates cellular metabolism and mRNA translation to potentiate macrophage activation.

Authors:  Xiaodi Su; Yingpu Yu; Yi Zhong; Eugenia G Giannopoulou; Xiaoyu Hu; Hui Liu; Justin R Cross; Gunnar Rätsch; Charles M Rice; Lionel B Ivashkiv
Journal:  Nat Immunol       Date:  2015-06-29       Impact factor: 25.606

8.  Jmjd3 contributes to the control of gene expression in LPS-activated macrophages.

Authors:  Francesca De Santa; Vipin Narang; Zhei Hwee Yap; Betsabeh Khoramian Tusi; Thomas Burgold; Liv Austenaa; Gabriele Bucci; Marieta Caganova; Samuele Notarbartolo; Stefano Casola; Giuseppe Testa; Wing-Kin Sung; Chia-Lin Wei; Gioacchino Natoli
Journal:  EMBO J       Date:  2009-09-24       Impact factor: 11.598

9.  A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response.

Authors:  Laurens Kruidenier; Chun-wa Chung; Zhongjun Cheng; John Liddle; KaHing Che; Gerard Joberty; Marcus Bantscheff; Chas Bountra; Angela Bridges; Hawa Diallo; Dirk Eberhard; Sue Hutchinson; Emma Jones; Roy Katso; Melanie Leveridge; Palwinder K Mander; Julie Mosley; Cesar Ramirez-Molina; Paul Rowland; Christopher J Schofield; Robert J Sheppard; Julia E Smith; Catherine Swales; Robert Tanner; Pamela Thomas; Anthony Tumber; Gerard Drewes; Udo Oppermann; Dinshaw J Patel; Kevin Lee; David M Wilson
Journal:  Nature       Date:  2012-08-16       Impact factor: 49.962

10.  Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages.

Authors:  Stanley Ching-Cheng Huang; Bart Everts; Yulia Ivanova; David O'Sullivan; Marcia Nascimento; Amber M Smith; Wandy Beatty; Latisha Love-Gregory; Wing Y Lam; Christina M O'Neill; Cong Yan; Hong Du; Nada A Abumrad; Joseph F Urban; Maxim N Artyomov; Erika L Pearce; Edward J Pearce
Journal:  Nat Immunol       Date:  2014-08-03       Impact factor: 25.606

View more
  247 in total

Review 1.  Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy.

Authors:  Jackie E Bader; Kelsey Voss; Jeffrey C Rathmell
Journal:  Mol Cell       Date:  2020-06-18       Impact factor: 17.970

Review 2.  Intracellular and Intercellular Aspects of Macrophage Immunometabolism in Atherosclerosis.

Authors:  Ira Tabas; Karin E Bornfeldt
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

3.  Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells.

Authors:  Min-Hee Oh; Im-Hong Sun; Liang Zhao; Robert D Leone; Im-Meng Sun; Wei Xu; Samuel L Collins; Ada J Tam; Richard L Blosser; Chirag H Patel; Judson M Englert; Matthew L Arwood; Jiayu Wen; Yee Chan-Li; Lukáš Tenora; Pavel Majer; Rana Rais; Barbara S Slusher; Maureen R Horton; Jonathan D Powell
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

4.  Immunometabolism: From basic mechanisms to translation.

Authors:  Liza Makowski; Mehdi Chaib; Jeffrey C Rathmell
Journal:  Immunol Rev       Date:  2020-05       Impact factor: 12.988

Review 5.  Immunometabolic Crosstalk: An Ancestral Principle of Trained Immunity?

Authors:  Sider Penkov; Ioannis Mitroulis; George Hajishengallis; Triantafyllos Chavakis
Journal:  Trends Immunol       Date:  2018-11-29       Impact factor: 16.687

Review 6.  Obesity, Hypertension, and Cardiac Dysfunction: Novel Roles of Immunometabolism in Macrophage Activation and Inflammation.

Authors:  Alan J Mouton; Xuan Li; Michael E Hall; John E Hall
Journal:  Circ Res       Date:  2020-03-12       Impact factor: 17.367

7.  More than a powerplant: the influence of mitochondrial transfer on the epigenome.

Authors:  Alexander N Patananan; Alexander J Sercel; Michael A Teitell
Journal:  Curr Opin Physiol       Date:  2017-12-13

Review 8.  Targeted Metabolic Reprogramming to Improve the Efficacy of Oncolytic Virus Therapy.

Authors:  Barry E Kennedy; Maryanne Sadek; Shashi A Gujar
Journal:  Mol Ther       Date:  2020-03-20       Impact factor: 11.454

9.  An association between mitochondria and microglia effector function. What do we think we know?

Authors:  G Jean Harry; Gabrielle Childers; Sahana Giridharan; Irisyunuel Lopez Hernandes
Journal:  Neuroimmunol Neuroinflamm       Date:  2020-06-16

10.  The angiocrine Rspondin3 instructs interstitial macrophage transition via metabolic-epigenetic reprogramming and resolves inflammatory injury.

Authors:  Bisheng Zhou; Lissette Magana; Zhigang Hong; Long Shuang Huang; Sreeparna Chakraborty; Yoshikazu Tsukasaki; Cary Huang; Li Wang; Anke Di; Balaji Ganesh; Xiaopei Gao; Jalees Rehman; Asrar B Malik
Journal:  Nat Immunol       Date:  2020-08-24       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.